Status:
RECRUITING
Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Makerere University
Columbia University
Conditions:
HIV Prevention
Eligibility:
FEMALE
15-24 years
Phase:
NA
Brief Summary
The study will employ a multilevel combination intervention focused on PrEP initiation and adherence among adolescent girls and young women (AGYW) (aged 15-24) living in HIV hotpots in Uganda. Specifi...
Detailed Description
Adolescent girls and young women (AGYW) aged 15-24 are twice as likely to be living with HIV than young men in Sub-Saharan Africa (SSA). HIV prevention strategies available to AGYW primarily depend on...
Eligibility Criteria
Inclusion
- Age 15-24 years
- At a high risk of HIV. AGYW will be deemed to be at substantial risk, and eligible to participate in the study, if they report at least one of the seven high-risk sexual behaviors on the risk assessment tool: 1) vaginal/anal sexual intercourse with more than one partner of unknown HIV status in the past six months, 2) vaginal/anal sex without a condom in the past six months, 3) sex in exchange for money, goods or a service in the last six months, 4) injecting drugs in the past six months, 5) diagnosis with an STI more than once in the past twelve months, 6) post-exposure prophylaxis (PEP) for sexual exposure to HIV in the past six months, and 7) having an HIV-infected sexual partner who was not on ART.
Exclusion
- HIV positive
- Unable to understand the study procedures and/or participant rights during the informed consent process
- Unwilling or unable to commit to completing the study
Key Trial Info
Start Date :
October 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT07002866
Start Date
October 20 2025
End Date
December 31 2029
Last Update
November 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St. Louis
St Louis, Missouri, United States, 63130
2
International Center for Child Health and Development (ICHAD)
Masaka, Uganda